Board change

RNS Number : 0009O

AstraZeneca PLC

27 February 2009

 



ASTRAZENECA PLC BOARD CHANGE

AstraZeneca today announced that Håkan Mogren, Non-Executive Deputy Chairman of AstraZeneca PLC, will retire from the Board at the close of the company's AGM on 30 April 2009.

Louis Schweitzer, Chairman of AstraZeneca PLC, said: 'As Chief Executive Officer of Astra AB, and subsequently Deputy Chairman of AstraZeneca, Håkan has made an excellent contribution to our business. He was instrumental in the formation of AstraZeneca and has brought a wealth of experience and sound judgement to our Board decisions. His fellow Directors and I thank him for his distinguished contribution to the company over two decades and wish him a long and very happy retirement.'

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US$ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. For more information about AstraZeneca, please visit: www.astrazeneca.com

Media Enquiries UK:
Chris Sampson	[phone] (24 hours)
Neil McCrae	[phone] (24 hours)
Sarah Lindgreen	[phone] (24 hours)
Investor Enquiries UK:
Jonathan Hunt	[phone]	mob: [phone]
Karl Hard	[phone]	mob: [phone]
Investor Enquiries US:
Ed Seage	[phone]	mob: [phone]
Jorgen Winroth	[phone]	mob: [phone]

27 February 2009

- ENDS -

 

END

 

 

BOADGGZZRNFGLZG